EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Altered GIP/GLP-1 Secretion Ratio is Associated With Impaired β Cell Function in Humans

Gianfranco Di Giuseppe iD, Giulia Gliozzo, Gea Ciccarelli, Lorenzo Carciero, Michela Brunetti, Laura Soldovieri, Giuseppe Quero, Francesca Cinti, Enrico Celestino Nista, Sara Sofia De Lucia, Antonio Gasbarrini iD, Sergio Alfieri und 6 weitere

The Journal of Clinical Endocrinology & Metabolism · 2025

DOI: 10.1210/clinem/dgaf210 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Gianfranco Di Giuseppe und 17 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology and Diabetology Unit, University Hospital Agostino Gemelli, 00168 Rome, Italy. Hauptthemen laut MEDLINE: Gastric Inhibitory Polypeptide, Glucagon-Like Peptide 1, Insulin-Secreting Cells, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università Cattolica del Sacro Cuore, Italian Ministry of Education, University, and Research, European Foundation for the Study of Diabetes.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The entero-insular axis, mediated by the incretin hormones glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1), is fundamental to maintaining glucose homeostasis. Dysregulation of these hormones’ biology contributes to the pathogenesis of type 2 diabetes (T2D), but the existence of a dysfunctional secretory pattern of incretins toward deterioration of glucose tolerance is still debated. In this study, we evaluate possible impairments in the overall incretin secretion from normal glucose tolerance to overt diabetes, as well as their association with impaired insulin secretion.

Methods

Sixty subjects with an unknown history of T2D who were not on antidiabetic treatments were divided into 3 groups according to oral glucose tolerance test-derived glucose tolerance: normal glucose tolerance (NGT) (n = 23), impaired glucose tolerance (IGT) (n = 16), and diabetes mellitus (DM) (n = 21). All subjects underwent deep metabolic evaluation with a mixed meal test (MMT) and euglycemic hyperinsulinemic clamp. During the MMT, we calculated the GIP/GLP-1 secretion ratio (SR) and the GIP/GLP-1 SR areas under the curve. Parameters of β cell function were obtained by mathematical modeling.

Results

Linear mixed model analysis revealed similar GIP and GLP-1 responses to MMT among the 3 groups, while GIP/GLP-1 SR was reduced in DM subjects compared to NGT and IGT. Further, multiple regression analysis showed a predictive role of GIP/GLP-1 SR on rate sensitivity and standardized insulin secretion at 5 mmol/L.

Conclusion

Our findings demonstrate that, despite similar GIP and GLP-1 secretion, the GIP/GLP-1 SR declines as glucose tolerance deteriorates, reflecting an imbalance in incretin dynamics rather than absolute hormone secretion. This imbalance may indicate early β cell dysfunction and chronic incretin resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastric Inhibitory PolypeptideGlucagon-Like Peptide 1Insulin-Secreting CellsDiabetes Mellitus, Type 2Glucose IntoleranceHumansMaleFemaleMiddle AgedGlucose Tolerance TestAgedInsulin SecretionAdultInsulinBlood GlucoseGlucose Clamp Technique

Stichwörter der Autor:innen

beta cell functionglucagon-like peptide 1glucose-dependent insulinotropic peptideincretin secretiontype 2 diabetes

Substanzen

Gastric Inhibitory PolypeptideGlucagon-Like Peptide 1InsulinBlood Glucose

Autor:innen und Institutionen

  • Endocrinology and Diabetology Unit, University Hospital Agostino Gemelli, 00168 Rome, Italy.
  • Department of Translational Medicine and Surgery, Catholic University of Sacred Heart, 00168 Rome, Italy.
  • Digestive Surgery Unit, University Hospital Agostino Gemelli, 00168 Rome, Italy.
  • Pancreas Unit, Digestive Diseases Center, University Hospital Agostino Gemelli, 00168 Rome, Italy.
  • Institute of Neuroscience, National Research Council, 2-35122 Padua, Italy.
  • Department of Biomedical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.

ORCID-Profile: Gianfranco Di Giuseppe, Antonio Gasbarrini, Andrea Mari, Bolette Hartmann, Andrea Giaccari, Teresa Mezza

Förderung

  • Università Cattolica del Sacro Cuore
  • Italian Ministry of Education, University, and Research
  • European Foundation for the Study of Diabetes
  • Astra Zeneca
  • MIUR
  • Università Cattolica del Sacro Cuore

Zitieren

APA

Di Giuseppe, G., Gliozzo, G., Ciccarelli, G., Carciero, L., Brunetti, M., Soldovieri, L., Quero, G., Cinti, F., Nista, E. C., De Lucia, S. S., Gasbarrini, A., Alfieri, S., Pontecorvi, A., Mari, A., Hartmann, B., Holst, J. J., Giaccari, A., & Mezza, T. (2025). Altered GIP/GLP-1 Secretion Ratio is Associated With Impaired β Cell Function in Humans. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaf210

Vancouver

Di Giuseppe G, Gliozzo G, Ciccarelli G, Carciero L, Brunetti M, Soldovieri L, et al. Altered GIP/GLP-1 Secretion Ratio is Associated With Impaired β Cell Function in Humans. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgaf210

BibTeX
@article{DiGiuseppe2025,
  author = {Di Giuseppe, Gianfranco and Gliozzo, Giulia and Ciccarelli, Gea and Carciero, Lorenzo and Brunetti, Michela and Soldovieri, Laura and Quero, Giuseppe and Cinti, Francesca and Nista, Enrico Celestino and De Lucia, Sara Sofia and Gasbarrini, Antonio and Alfieri, Sergio and Pontecorvi, Alfredo and Mari, Andrea and Hartmann, Bolette and Holst, Jens Juul and Giaccari, Andrea and Mezza, Teresa},
  title = {Altered GIP/GLP-1 Secretion Ratio is Associated With Impaired β Cell Function in Humans},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  doi = {10.1210/clinem/dgaf210}
}
Kostenlos starten →